Camp4 Therapeutics Corp (CAMP) stock
CAMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3057% above fair value
$3.80−0.29 (-7.09%)
Close on Nov 13, 2026Market cap $238.46MP/E –Yield 0.00%
Camp4 Therapeutics cash
Cash and short-term investments held at the end of each period.
Camp4 Therapeutics's cash was $124.52M at Sep 30, 2026. For fiscal 2025 it was $109.52M, up 66.8% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.52M | +66.8% |
| FY2024 | Dec 31, 2024 | $65.66M | +64.1% |
| FY2023 | Dec 31, 2023 | $40.00M | -52.7% |
| FY2022 | Dec 31, 2022 | $84.54M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $124.52M | +62.0% |
| Q2 FY2026 | Jun 30, 2026 | $86.40M | +112.4% |
| Q1 FY2026 | Mar 31, 2026 | $99.21M | +94.7% |
| Q4 FY2025 | Dec 31, 2025 | $109.52M | +66.8% |
| Q3 FY2025 | Sep 30, 2025 | $76.88M | +1751.6% |
| Q2 FY2025 | Jun 30, 2025 | $40.68M | +185.8% |
| Q1 FY2025 | Mar 31, 2025 | $50.95M | +77.9% |
| Q4 FY2024 | Dec 31, 2024 | $65.66M | +64.1% |
| Q3 FY2024 | Sep 30, 2024 | $4.15M | -91.8% |
| Q2 FY2024 | Jun 30, 2024 | $14.23M | -83.2% |
| Q1 FY2024 | Mar 31, 2024 | $28.64M | – |
| Q4 FY2023 | Dec 31, 2023 | $40.00M | – |
| Q3 FY2023 | Sep 30, 2023 | $50.47M | – |
| Q4 FY2022 | Dec 31, 2022 | $84.54M | – |
See a number that looks wrong?